Immunocore Holdings Correlations
IMCR Stock | USD 32.83 0.38 1.17% |
The current 90-days correlation between Immunocore Holdings and Arcellx is 0.28 (i.e., Modest diversification). The correlation of Immunocore Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Immunocore Holdings Correlation With Market
Weak diversification
The correlation between Immunocore Holdings and DJI is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Immunocore Holdings and DJI in the same portfolio, assuming nothing else is changed.
Immunocore |
Moving together with Immunocore Stock
0.68 | ACRV | Acrivon Therapeutics, | PairCorr |
0.7 | AFMD | Affimed NV | PairCorr |
0.69 | STOK | Stoke Therapeutics | PairCorr |
Moving against Immunocore Stock
0.53 | MNOV | MediciNova | PairCorr |
0.46 | OPT | Opthea | PairCorr |
0.4 | ABEO | Abeona Therapeutics | PairCorr |
0.36 | ACIU | AC Immune | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Immunocore Stock performing well and Immunocore Holdings Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Immunocore Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ACLX | 2.41 | 0.12 | 0.08 | 0.17 | 2.84 | 6.28 | 15.13 | |||
VTYX | 3.36 | 0.09 | 0.08 | 0.15 | 3.12 | 6.96 | 16.88 | |||
PCVX | 2.25 | 0.48 | 0.10 | (0.36) | 2.19 | 3.32 | 42.81 | |||
DICE | 2.09 | 0.67 | 0.30 | (2.55) | 1.14 | 5.66 | 37.64 | |||
NUVL | 2.22 | 0.09 | 0.06 | 0.17 | 2.76 | 3.84 | 36.85 | |||
VRDN | 3.19 | 0.48 | 0.15 | 0.37 | 3.44 | 6.84 | 44.89 | |||
GRCL | 5.71 | 1.16 | 0.18 | 0.62 | 6.35 | 16.34 | 52.11 | |||
THRX | 5.44 | (0.66) | 0.00 | (0.61) | 0.00 | 11.75 | 90.33 | |||
GLUE | 4.99 | 0.61 | 0.18 | 0.32 | 3.86 | 7.42 | 102.66 |
Immunocore Holdings Corporate Management
Sbastien Desprez | Head Communications | Profile | |
Debra Nielsen | Chief Staff | Profile | |
JD Esq | Chief Officer | Profile | |
Annelise Vuidepot | CTO Research | Profile | |
Brian MBA | CFO Strategy | Profile | |
Amy JudgePrein | Chief Officer | Profile |